Developing a non-invasive method for definitively diagnosing intracranial neoplasms would reduce the risks involved with diagnosis and improve the treatment of such tumors. We used magnetoencephalography to measure the power spectral densities of malignant brain tumor cells in vitro and found that meningioma and medulloblastoma cells produce unique electromagnetic signatures. Our results suggest that non-invasive identification of neoplastic tissue is possible through the use of magnetoencephalography.
Approximately 21,000 new primary brain tumors are diagnosed each year in the United States 1 .
Identifying the specific tumor type is essential for prescribing treatment and determining prognosis, but We chose two cell lines, M4 (meningioma) and DAOY (medulloblastoma), because meningioma and medulloblastoma are known to have increased EM activity in specific frequency bands. To determine whether these brain tumor cells produce distinct EM activity, we acquired two 30-second recordings of the neuromagnetic signal for each flask containing a brain tumor cell line and compared them to a flask containing only media. Two flasks were examined for each cell line. Each flask was placed in the center of the cryogenic dewar of a WH3600
whole-head neuromagnetometer (4D Neuroimaging, San Diego, CA), which was located in a magnetically shielded room. The signal was sampled at 500 Hz (bandpass: 0.01 to 50 Hz). To characterize the frequency distribution of the signal, we derived the power spectral density (PSD). The PSD provides a measure of watts (i.e., signal power) at each frequency. To derive this measure, we performed a discrete fast-Fourier transform on the signal from each of the 248 axial gradiometers. Each signal was analyzed by sliding the 512-point short-window discrete fast-Fourier transform across the time dimension such that each sequential segment overlapped with the previous segment by 50%.
To analyze the difference in power across cell lines and frequencies, we used a mixed-model analysis of variance (ANOVA). Frequency was divided into four ranges, delta (1-3 Hz), theta (4-7 Hz), alpha (8-12 Hz), and beta (13-30 Hz), and the power within each range was the average across the frequency range. Data from each run and flask were entered into the ANOVA, and orthogonal post-hoc contrasts with Bonferroni correction were used to examine group and frequency differences. The criteria for statistical significance was p=0.01. Each flask was considered a separate subject. Supplementary Table 1) .
Research similar to our study has focused on low-frequency EM activity associated with brain tumors. 
